Gaush Meditech Ltd
Gaush Meditech Ltd. engages in the research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers. The company's product portfolio comprising proprietary products, which it develops and manufactures, as well as distribution products of its brand partners, which it distributes, covering seven ophthalm… Read more
Gaush Meditech Ltd (F7Y) - Total Assets
Latest total assets as of June 2025: €2.57 Billion EUR
Based on the latest financial reports, Gaush Meditech Ltd (F7Y) holds total assets worth €2.57 Billion EUR as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Gaush Meditech Ltd - Total Assets Trend (2021–2024)
This chart illustrates how Gaush Meditech Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Gaush Meditech Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Gaush Meditech Ltd's total assets of €2.57 Billion consist of 44.8% current assets and 55.2% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 16.4% |
| Accounts Receivable | €166.44 Million | 6.5% |
| Inventory | €334.42 Million | 13.0% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €294.42 Million | 11.5% |
| Goodwill | €910.51 Million | 35.5% |
Asset Composition Trend (2021–2024)
This chart illustrates how Gaush Meditech Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Gaush Meditech Ltd's current assets represent 44.8% of total assets in 2024, a decrease from 44.9% in 2021.
- Cash Position: Cash and equivalents constituted 16.4% of total assets in 2024, down from 25.1% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 46.0% of total assets, a decrease from 48.0% in 2021.
- Asset Diversification: The largest asset category is goodwill at 35.5% of total assets.
Gaush Meditech Ltd Competitors by Total Assets
Key competitors of Gaush Meditech Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Gaush Meditech Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Gaush Meditech Ltd generates 0.56x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Gaush Meditech Ltd generates $ 3.60 in net profit.
Gaush Meditech Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.40 | 1.87 | 1.87 |
| Quick Ratio | 1.57 | 1.38 | 1.38 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €609.04 Million | € 646.54 Million | € 646.54 Million |
Gaush Meditech Ltd - Advanced Valuation Insights
This section examines the relationship between Gaush Meditech Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -9.8% |
| Total Assets | €2.57 Billion |
| Market Capitalization | $29.55 Million USD |
Valuation Analysis
Below Book Valuation: The market values Gaush Meditech Ltd's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Gaush Meditech Ltd's assets decreased by 9.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Gaush Meditech Ltd (2021–2024)
The table below shows the annual total assets of Gaush Meditech Ltd from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €2.57 Billion | -9.76% |
| 2023-12-31 | €2.84 Billion | +4.62% |
| 2022-12-31 | €2.72 Billion | +12.01% |
| 2021-12-31 | €2.43 Billion | -- |